Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
31.94
-0.56 (-1.72%)
At close: Jul 6, 2026, 4:00 PM EDT
31.96
+0.02 (0.06%)
After-hours: Jul 6, 2026, 5:05 PM EDT

Immunocore Holdings Revenue

Immunocore Holdings had revenue of $106.68M in the quarter ending March 31, 2026, with 13.63% growth. This brings the company's revenue in the last twelve months to $412.81M, up 23.75% year-over-year. In the year 2025, Immunocore Holdings had annual revenue of $400.02M with 28.95% growth.

Revenue (ttm)
$412.81M
Revenue Growth
+23.75%
P/S Ratio
3.94
Revenue / Employee
$787,809
Employees
524
Market Cap
1.62B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025400.02M89.81M28.95%
Dec 31, 2024310.20M60.77M24.37%
Dec 31, 2023249.43M215.75M640.71%
Dec 31, 202233.67M-2.81M-7.70%
Dec 31, 202136.48M-4.69M-11.39%
Dec 31, 202041.17M7.13M20.95%
Dec 31, 201934.04M3.91M12.98%
Dec 31, 201830.13M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition